brivaracetam

FDA approves expanded indication for UCB’s Briviact to treat pediatric patients
Pharmaceutical Business Review
Tue, 08/31/21 - 10:57 am
UCB Pharma
FDA
partial onset seizures
pediatric
brivaracetam
Belgium's UCB leans on RTP work force for epilepsy drug application
Bizjournals.com
Fri, 01/23/15 - 11:47 am
UCB Pharma
epilepsy
R&D
brivaracetam
UCB Reports Phase III Data on Epilepsy Drug, To File in 2015
Yahoo/Zacks.com
Tue, 12/9/14 - 04:05 pm
UCB Pharmaceuticals
epilepsy
brivaracetam
UCB inches toward the FDA with its latest epilepsy contender
Fierce Biotech
Thu, 07/24/14 - 09:56 am
UCB Pharmaceuticals
FDA
epilepsy
brivaracetam